NM_005506.4:c.475A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005506.4(SCARB2):​c.475A>G​(p.Met159Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00924 in 1,614,106 control chromosomes in the GnomAD database, including 98 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0093 ( 90 hom. )

Consequence

SCARB2
NM_005506.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.140

Publications

16 publications found
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
SCARB2 Gene-Disease associations (from GenCC):
  • action myoclonus-renal failure syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0078088045).
BP6
Variant 4-76179654-T-C is Benign according to our data. Variant chr4-76179654-T-C is described in ClinVar as Benign. ClinVar VariationId is 206702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00836 (1273/152336) while in subpopulation NFE AF = 0.0126 (859/68036). AF 95% confidence interval is 0.0119. There are 8 homozygotes in GnomAd4. There are 614 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005506.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
NM_005506.4
MANE Select
c.475A>Gp.Met159Val
missense
Exon 4 of 12NP_005497.1
SCARB2
NM_001204255.2
c.276-3744A>G
intron
N/ANP_001191184.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
ENST00000264896.8
TSL:1 MANE Select
c.475A>Gp.Met159Val
missense
Exon 4 of 12ENSP00000264896.2
SCARB2
ENST00000638295.1
TSL:5
c.1A>Gp.Met1?
start_lost
Exon 4 of 12ENSP00000492288.1
SCARB2
ENST00000640634.1
TSL:5
c.595A>Gp.Met199Val
missense
Exon 5 of 13ENSP00000492737.1

Frequencies

GnomAD3 genomes
AF:
0.00837
AC:
1274
AN:
152218
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00909
Gnomad ASJ
AF:
0.0133
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00932
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0126
Gnomad OTH
AF:
0.0139
GnomAD2 exomes
AF:
0.00861
AC:
2163
AN:
251304
AF XY:
0.00872
show subpopulations
Gnomad AFR exome
AF:
0.00215
Gnomad AMR exome
AF:
0.00778
Gnomad ASJ exome
AF:
0.0129
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00990
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0127
GnomAD4 exome
AF:
0.00933
AC:
13636
AN:
1461770
Hom.:
90
Cov.:
31
AF XY:
0.00936
AC XY:
6810
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.00239
AC:
80
AN:
33478
American (AMR)
AF:
0.00807
AC:
361
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0132
AC:
345
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.00136
AC:
117
AN:
86258
European-Finnish (FIN)
AF:
0.0107
AC:
570
AN:
53378
Middle Eastern (MID)
AF:
0.0255
AC:
147
AN:
5768
European-Non Finnish (NFE)
AF:
0.0102
AC:
11383
AN:
1111934
Other (OTH)
AF:
0.0104
AC:
629
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
736
1473
2209
2946
3682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00836
AC:
1273
AN:
152336
Hom.:
8
Cov.:
33
AF XY:
0.00824
AC XY:
614
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00209
AC:
87
AN:
41574
American (AMR)
AF:
0.00908
AC:
139
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
46
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.00932
AC:
99
AN:
10626
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0126
AC:
859
AN:
68036
Other (OTH)
AF:
0.0137
AC:
29
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
65
130
194
259
324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0107
Hom.:
45
Bravo
AF:
0.00824
TwinsUK
AF:
0.00944
AC:
35
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0120
AC:
103
ExAC
AF:
0.00896
AC:
1088
Asia WGS
AF:
0.00173
AC:
7
AN:
3478
EpiCase
AF:
0.0135
EpiControl
AF:
0.0136

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
1
Action myoclonus-renal failure syndrome (1)
-
-
1
Focal segmental glomerulosclerosis (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Progressive myoclonic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
9.8
DANN
Benign
0.56
DEOGEN2
Benign
0.12
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.98
L
PhyloP100
-0.14
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.43
N
REVEL
Benign
0.13
Sift
Benign
0.45
T
Sift4G
Benign
0.31
T
Polyphen
0.0
B
Vest4
0.11
MVP
0.40
MPC
0.24
ClinPred
0.00036
T
GERP RS
-2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.095
gMVP
0.53
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143655258; hg19: chr4-77100807; COSMIC: COSV106369910; COSMIC: COSV106369910; API